TG

Thiyagarajan Gunaseelan

Director DIN 03640163
DIN 03640163 First appointment Nov 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Thiyagarajan Gunaseelan

Data last updated:

Thiyagarajan Gunaseelan was a Director at Energamp Biotech Private Limited (from 2011) and Director at Thot Analytics Consulting Private Limited (from 2012).

DIN 03640163
First Appointment 03 Nov 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Energamp Biotech Private Limited U74900TN2011PTC082988
Director03 Nov 20112011Strike Off
Director03 Dec 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Energamp Biotech Private Limited
Thot Analytics Consulting Private Limited
Premium access

Shareholding and investment profile for Thiyagarajan Gunaseelan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thiyagarajan Gunaseelan

Thiyagarajan Gunaseelan was first appointed on 03 Nov 2011 as Director at Energamp Biotech Private Limited. The most recent appointment on record is 03 Dec 2012 at Thot Analytics Consulting Private Limited.

Thiyagarajan Gunaseelan held 2 earlier board appointments: Energamp Biotech Private Limited (Director, from 03 Nov 2011); Thot Analytics Consulting Private Limited (Director, from 03 Dec 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available